Önder ÇINAR
(Zonguldak Bülent Ecevit Üniversitesi, Tıp Fakültesi, Üroloji Anabilim Dalı, Zonguldak, Türkiye)
Mustafa BOLAT
(Samsun Gazi Hastanesi, Üroloji Kliniği, Samsun, Türkiye)
Kemal ÖZTÜRK
(Samsun Gazi Hastanesi, Üroloji Kliniği, Samsun, Türkiye)
Yıl: 2020Cilt: 7Sayı: 3ISSN: 2148-9580Sayfa Aralığı: 158 - 165İngilizce

42 0
Should the Double-J Stent Be Removed Endoscopically after a Ureteroscopic Stone Surgery?
Objective: Ureterorenoscopic stone surgery (USS) is the primary method of ureteral stone treatment. Double-J (JJ) stenting is an integral part of a USS, and most urologists prefer to use it without an extraction string. The probable reason for such preference could be the lack of reliable and sufficient data on JJ stent use with an extraction string. Materials and Methods: A total of 177 patients who underwent USS were divided into four groups: Group 1 men (JJ stent was manually removed), group 2 men (JJ stent was cystoscopically removed), group 3 women (JJ stent was manually removed), and group 4 women (JJ stent was cystoscopically removed). We investigated the impact of two different JJ stent removal techniques on pain perception, lower urinary tract symptoms (LUTS), depressive symptomatology, complications, and cost. Results: Compared to groups 1 and 3, the mean surgery times were higher in groups 2 and 4 (p=0.001). Preoperative LUTS scores were similar in all groups (p>0.05). Postoperative pain scores in groups 3 and 4 were similar (p=0.06), but they were lower in group 1 than in group 2 (p=0.004). Postoperative Beck depression inventory scores were lower in groups 1 and 3 (p<0.02). The total cost of USS was 28.5% higher in groups 2 and 4 compared to groups 1 and 3. Conclusion: It is concluded that JJ stent removal with an extraction string is a reliable method with low treatment costs that does not adversely affect surgical outcomes.
DergiAraştırma MakalesiErişime Açık
  • 1. Ordonez M, Hwang EC, Borofsky M, Bakker CJ, Gandhi S, Dahm P. Ureteral stent versus no ureteral stent for ureteroscopy in the management of renal and ureteral calculi. Cochrane Database Syst Rev 2019;2:CD012703.
  • 2. Assimos D, Krambeck A, Miller NL, Monga M, Murad MH, Nelson CP, Pace KT, Pais VM Jr, Pearle MS, Preminger GM, Razvi H, Shah O, Matlaga BR. Surgical Management of Stones: American Urological Association/Endourological Society Guideline, PART I. J Urol 2016;196:1153-1160.
  • 3. Bockholt NA, Wild TT, Gupta A, Tracy CR. Ureteric stent placement with extraction string: no strings attached? BJU Int 2012;110:E1069-1073.
  • 4. Oliver R, Wells H, Traxer O, Knoll T, Aboumarzouk O, Biyani CS, Somani BK; YAU Group. Ureteric stents on extraction strings: a systematic review of literature. Urolithiasis 2018;46:129–136.
  • 5. Ghani KR, Roghmann F, Sammon JD, Trudeau V, Sukumar S, Rahbar H, Kumar R, Karakiewicz PI, Peabody JO, Menon M, Sun M, Trinh QD. Emergency department visits in the United States for upper urinary tract stones: trends in hospitalization and charges. J Urol 2014;191:90-96.
  • 6. Raheem OA, Khandwala YS, Sur RL, Ghani KR, Denstedt JD. Burden of Urolithiasis: Trends in Prevalence, Treatments, and Costs. Eur Urol Focus 2017;3:18-26.
  • 7. Racioppi M, Palermo G, D’Addessi A, Pinto F, Sacco E, D’Agostino D, Vittori M, Bassi PF. Hot topics in urological health economics. A mini review. Arch Ital Urol Androl 2012;84:47-52.
  • 8. Cam K, Senel F, Akman Y, Erol A. The efficacy of an abbreviated model of the International Prostate Symptom Score in evaluating benign prostatic hyperplasia. BJU Int 2003;91:186-189.
  • 9. Tsuji FH, Chambó RC, Agostinho AD, Trindade Filho JC, de Jesus CM. Sedoanalgesia with midazolam and fentanyl citrate controls probe pain during prostate biopsy by transrectal ultrasound. Korean J Urol 2014;55:106-111.
  • 10. Mertoğlu O, Üçer O, Ceylan Y, Bozkurt O, Günlüsoy B, Albaz AC, Demir Ö;Aegean Study Group of Society of Urological Surgery. Reliability and Validity of the Turkish Language Version of the International Consultation on Incontinence Questionnaire - Male Lower Urinary Tract Symptoms. Int Neurourol J 2016;20:159-163.
  • 11. Beck, AT, Steer, RA, & Brown, GK. Manual for the Beck Depression Inventory- II. San Antonio, TX: Psychological Corporation.
  • 12. Wang CJ, Huang SW, Chang CH. Effects of tamsulosin on lower urinary tract symptoms due to double-J stent: a prospective study. Urol Int 2009;83:66- 69.
  • 13. Haleblian G, Kijvikai K, de la Rosette J, Preminger G. Ureteral stenting and urinary stone management: a systematic review. J Urol 2008;179:424-430.
  • 14. Kuyumcuoglu U, Eryildirim B, Tuncer M, Faydaci G, Tarhan F, Ozgül A. Effectiveness of medical treatment in overcoming the ureteral double-J stent related symptoms. Can Urol Assoc J 2012;6:234-237.
  • 15. Abrams P, Avery K, Gardener N, Donovan J. The international consultation on incontinence modular questionnaire. J Urol 2006;175:1063-1066.
  • 16. Ray RP, Mahapatra RS, Mondal PP, Pal DK. Long- term complications of JJ stent and its management: A 5 years review. Urol Ann 2015;7:41-45.
  • 17. Scarneciu I, Lupu S, Pricop C, Scarneciu C. Morbidity and impact on quality of life in patients with indwelling ureteral stents: A 10- year clinical experience. Pak J Med Sci 2015;31:522-526.
  • 18. Barnes KT, Bing MT, Tracy CR. Do ureteric stent extraction strings affect stent-related quality of life or complications after ureteroscopy for urolithiasis: a prospective randomized. BJU Int 2014;113:605-609.
  • 19. York N, English S. Self-removal of ureteric JJ stents: analysis of patient experience. J Urol 2013;189:812.
  • 20. Singh V, Srinivastava A, Kapoor R, Kumar A. Can the complicated forgotten indwelling ureteric stents be lethal? Int Urol Nephrol 2005;37:541-546.
  • 21. Sancaktutar AA, Soylemez H, Bozkurt Y, Penbegul N, Atar M. Treatment of forgotten ureteral stents: how much does it really cost? A cost-effectiveness study in 27 patients. Urol Res 2012;40:317-325.
  • 22. Barnes KT, Bing MT, Tracy CR. Do ureteric stent extraction strings affect stent-related quality of life or complications after ureteroscopy for urolithiasis: a prospective randomised control trial. BJU Int 2014;113:605- 609.
  • 23. Ishii H, Couzins M, Aboumarzouk O, Biyani CS, Somani BK. Outcomes of systematic review of ureteroscopy for stone disease in the obese and morbidly obese population. J Endourol 2016;30:135-145.
  • 24. Rukin NJ, Siddiqui ZA, Chedgy ECP, Somani BK. Trends in Upper Tract Stone Disease in England: Evidence from the Hospital Episodes Statistics Database. Urol Int 2017;98:391-396.

TÜBİTAK ULAKBİM Ulusal Akademik Ağ ve Bilgi Merkezi Cahit Arf Bilgi Merkezi © 2019 Tüm Hakları Saklıdır.